纤维蛋白原结合抑制剂肽
中文名称 | 纤维蛋白原结合抑制剂肽 |
---|---|
中文同义词 | HV-12;L-缬氨酸,L-组氨酰-L-组氨酰-L-亮氨酰甘氨酰甘氨酰-L-丙氨酰-L-赖氨酰-L-谷酰 |
英文名称 | HIS-HIS-LEU-GLY-GLY-ALA-LYS-GLN-ALA-GLY-ASP-VAL |
英文同义词 | FIBRINOGEN Y-CHAIN DODECAPETIDE;FIBRINOGEN GAMMA-CHAIN DODECAPEPTIDE;FIBRINOGEN-BINDING INHIBITOR PEPTIDE;HUMAN FIBRINOGEN-GAMMA FRAGMENT 400-411;HHLGGAKQAGDV;H-HIS-HIS-LEU-GLY-GLY-ALA-LYS-GLN-ALA-GLY-ASP-VAL-OH;HIS-HIS-LEU-GLY-GLY-ALA-LYS-GLN-ALA-GLY-ASP-VAL;fibrinogen-γ fragment 400-411 |
CAS号 | 89105-94-2 |
分子式 | C50H80N18O16 |
分子量 | 1189.28 |
EINECS号 | |
相关类别 | 多肽;目录多肽;peptide |
Mol文件 | 89105-94-2.mol |
结构式 |
纤维蛋白原结合抑制剂肽 性质
沸点 | 1809.9±65.0 °C(Predicted) |
---|---|
密度 | 1.342±0.06 g/cm3(Predicted) |
储存条件 | −20°C |
形态 | 固体 |
酸度系数(pKa) | 3.20±0.10(Predicted) |
序列 | H-His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-Val-OH |
Glycoprotein (GP) IIb/IIIa, which exists on the membrane of platelets, changes its form from inactive to active when platelets adhere to collagen exposed on sites of vascular injury. In the circulation, platelet aggregation is mediated by fibrinogen by bridging adjacent platelets through GPIIb/IIIa in an activation-dependent manner. A dodecapeptide HHLGGAKQAGDV (H12), corresponding to the fibrinogen γ-chain carboxy-terminal sequence (γ400-411), is a specific binding site of the ligand for activated GPIIb/IIIa
纯度(HPLC) ≥98.0%
醋酸根含量≤12.0%
水分含量≤8.0%
肽含量≥80.0%
内毒素≤50EU/mg
氨基酸组成分析≤±10%
安全信息
WGK Germany | 3 |
---|
提供商 | 语言 |
---|---|
英文
|
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024/01/25 | HY-P1507 | FIBRINOGEN-BINDING INHIBITOR PEPTIDE Fibrinogen Binding Inhibitor Peptide | 89105-94-2 | 1mg | 800元 |
2024/01/25 | HY-P1507 | FIBRINOGEN-BINDING INHIBITOR PEPTIDE Fibrinogen Binding Inhibitor Peptide | 89105-94-2 | 5mg | 1900元 |